AJP Legacy Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol 186: 180-186, 1956;
0002-9513/56 $5.00
This Article
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baer, J. E.
Right arrow Articles by Beyer, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baer, J. E.
Right arrow Articles by Beyer, K. H.

Renal Elimination of 3-Methylaminoisocamphane Hydrochloride (Mecamylamine)

John E. Baer 1, Sue F. Paulson 1, Horace F. Russo 1, and Karl H. Beyer 1

1 From the Merck Institute for Therapeutic Research, West Point, Pennsylvania

Mecamylamine, 3-methylaminoisocamphane hydrochloride, a secondary amine with a pka of 11.4, can be both actively secreted and actively reabsorbed by the renal tubules in the dog. Net secretion occurs when the urine is acid; net reabsorption occurs when the urine is alkaline. A direct renal extraction study showed that tubular secretion occurred at rates equal to effective renal plasma flow. No self-depression of tubular secretion was observed at increased loads. The clearance of mecamylamine was depressed below glomerular filtration rate when the urine became alkaline, whether or not a systemic alkalosis existed. In some experiments, the clearance was as low as 3 ml/min., corresponding to reabsorption of more than 90% of the filtered drug. The secretory mechanism is not identical with that for p-aminohippurate. Approximately one-fourth of an administered dose of mecamylamine is excreted in the urine within 24 hours, whether the drug is given orally or parenterally. These data are consistent with the biological evidence that absorption from the gastrointestinal tract is essentially complete, and that extrarenal factors are important in the over-all physiological economy of the drug.

Submitted on January 18, 1956




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
R. L. Papke, P. R. Sanberg, and R. D. Shytle
Analysis of Mecamylamine Stereoisomers on Human Nicotinic Receptor Subtypes
J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 646 - 656.
[Abstract] [Full Text]


Home page
JAMAHome page
E. A. Deagle III, T. R. Berigan, D. O. Antonuccio, W. G. Danton, E. F. Domino, J. Goldman, R. D. Shytle, P. R. Sanberg, J. Hughes, M. Goldstein, et al.
Adding Behavioral Therapy to Medication for Smoking Cessation
JAMA, June 2, 1999; 281(21): 1983 - 1985.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 1956 by the American Physiological Society.